Evidence for selective transformation of autoreactive immature plasma cells in mice deficient in Fasl

Journal of Experimental Medicine

Volumn 200, Issue 11, 2004, Pages 1467-1478

  Zhang, Jian Qiao ^a   Okumura, Cheryl ^b,c   McCarty, Thomas ^b,d   Shin, Min Sun ^b   Mukhopadhyay, Partha ^a   Hori, Mitsuo ^b,e   Torrey, Ted A ^b   Naghashfar, Zohreh ^b   Zhou, Jeff X ^b   Lee, Chang Hoon ^b   Roopenian, Derry C ^f   Morse III, Herbert C ^b   Davidson, Wendy F ^a,g,h  

^a HOLLAND LABORATORY   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d TRANSLATIONAL GENOMICS RESEARCH INSTITUTE   (United States)

^e IBARAKI PREFECTURAL CENTRAL HOSPITAL   (Japan)

^f JACKSON LABORATORY   (United States)

^g GEORGE WASHINGTON UNIVERSITY   (United States)

^h UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER   (United States)

Author keywords

Autoimmunity; B cell lymphoma

Indexed keywords

ANTIGEN; ANTINUCLEAR ANTIBODY; FAS ANTIGEN; IMMUNOGLOBULIN; RHEUMATOID FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; B CELL LYMPHOMA; B LYMPHOCYTE; CARCINOGENESIS; CELL MATURATION; CELL TRANSFORMATION; CONTROLLED STUDY; GENE EXPRESSION PROFILING; GENE REARRANGEMENT; GENETIC TRANSCRIPTION; IMMUNOREACTIVITY; MOUSE; MOUSE STRAIN; NONHUMAN; PLASMA CELL; PRIORITY JOURNAL;

ANIMALS; ANTIBODY SPECIFICITY; AUTOIMMUNITY; B-LYMPHOCYTES; CELL TRANSFORMATION, NEOPLASTIC; FAS LIGAND PROTEIN; GENE EXPRESSION PROFILING; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN VARIABLE REGION; LYMPHOMA, B-CELL; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; PLASMA CELLS;

EID: 10644242583     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20041575     Document Type: Article

References (75)

1. Cohen, P.L., and R.A. Eisenberg. 1991. Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Annu. Rev. Immunol. 9:243-269.
2. Davidson, W.F., T. Giese, and T.N. Fredrickson. 1998. Spontaneous development of plasmacytoid tumors in mice with defective Fas-Fas ligand interactions. J. Exp. Med. 187: 1825-1838.
3. Radic, M.Z., and M.G. Weigert. 1994. Genetic and structural evidence for antigen selection of anti-DNA antibodies. Annu. Rev. Immunol. 12:487-520.
4. Shlomchik, M.J., A.H. Aucoin, D.S. Pisetsky, and M.G. Weigert. 1987. Structure and function of anti-DNA autoantibodies derived from a single autoimmune mouse. Proc. Natl. Acad. Sci. USA. 84:9150-9154.
5. 1 mice. J. Exp. Med. 176:761-779.
6. Straus, S.E., E.S. Jaffe, J.M. Puck, J.K. Dale, K.B. Elkon, A. Rosen-Wolff, A.M. Peters, M.C. Sneller, C.W. Hallahan, J. Wang, et al. 2001. The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis. Blood. 98:194-200.
7. Lossos, I.S., C.Y. Okada, R. Tibshirani, R. Warnke, J.M. Vose, T.C. Greiner, and R. Levy. 2000. Molecular analysis of immunoglobulin genes in diffuse large B-cell lymphomas. Blood. 95:1797-1803.
8. Lossos, I.S., A.A. Alizadeh, M.B. Eisen, W.C. Chan, P.O. Brown, D. Botstein, L.M. Staudt, and R. Levy. 2000. Ongoing immunoglobulin somatic mutation in germinal center B cell-like but not in activated B cell-like diffuse large cell lymphomas. Proc. Natl. Acad. Sci. USA. 97:10209-10213.
9. Kuppers, R., K. Rajewsky, and M.L. Hansmann. 1997. Diffuse large cell lymphomas are derived from mature B cells carrying V region genes with a high load of somatic mutation and evidence of selection for antibody expression. Eur. J. Immunol. 27:1398-1405.
10. Vescio, R.A., J. Cao, C.H. Hong, J.C. Lee, C.H. Wu, M. Der Danielian, V. Wu, R. Newman, M.Z. Radic, and M.G. Weigert. 1994. Genetic and structural evidence for antigen selection of anti-DNA antibodies. Annu. Rev. Immunol. 12: 487-520.
11. De Re, V., S. De Vita, A. Marzotto, M. Rupolo, A. Gloghini, B. Pivetta, D. Gasparotto, A. Carbone, and M. Boiocchi. 2000. Sequence analysis of the immunoglobulin antigen receptor of hepatitis C virus-associated non-Hodgkin lymphomas suggests that the malignant cells are derived from the rheumatoid factor-producing cells that occur mainly in type II cryoglobulinemia. Blood. 96:3578-3584.
12. Bahler, D.W., and R. Levy. 1992. Clonal evolution of a follicular lymphoma: evidence for antigen selection. Proc. Natl. Acad. Sci. USA. 89:6770-6774.
13. Matolcsy, A., E.J. Schattner, D.M. Knowles, and P. Casali. 1999. Clonal evolution of B cells in transformation from low- to high-grade lymphoma. Eur. J. Immunol. 29:1253-1264.
14. Mariette, X. 2001. Lymphomas complicating Sjögren's syndrome and hepatitis C virus infection may share a common pathogenesis: chronic stimulation of rheumatoid factor B cells. Ann. Rheum. Dis. 60:1007-1010.
15. Hyjek, E., W.J. Smith, and P.G. Isaacson. 1988. Primary B-cell lymphoma of salivary glands and its relationship to myoepithelial sialadenitis. Hum. Pathol. 19:766-776.
16. Hyjek, E., and P.G. Isaacson. 1988. Primary B cell lymphoma of the thyroid and its relationship to Hashimoto's thyroiditis. Hum. Pathol. 19:1315-1326.
17. De Re, V., S. De Vita, D. Gasparotto, A. Marzotto, A. Carbone, G. Ferraccioli, and M. Boiocchi. 2002. Salivary gland B cell lymphoproliferative disorders in Sjögren's syndrome present a restricted use of antigen receptor gene segments similar to those used by hepatitis C virus-associated non-Hodgkins's lymphomas. Eur. J. Immunol. 32:903-910.
18. Martin, T., C. Weber, H. Levallois, N. Labouret, A. Soley, S. Koenig, A.S. Korganow, and J.L. Pasquali. 2000. Salivary gland lymphomas in patients with Sjögren's syndrome may frequently develop from rheumatoid factor B cells. Arthritis Rheum. 43:908-916.
19. Eng, M.A., U. Kallemuchikkal, and P.D. Gorevic. 2000. Hepatitis C virus, autoimmunity and lymphoproliferation. Mt. Sinai J. Med. 67:120-132.
20. Peng, S.L., M.E. Robert, A.C. Hayday, and J. Craft. 1996. A tumor-suppressor function for Fas (CD95) revealed in T cell-deficient mice. J. Exp. Med. 184:1149-1154.
21. Hartley, J.W., S.K. Chattopadhyay, M.R. Lander, L. Taddesse-Heath, Z. Naghashfar, H.C. Morse III, and T.N. Fredrickson. 2000. Accelerated appearance of multiple B cell lymphoma types in NFS/N mice congenic for ecotropic murine leukemia viruses. Lab. Invest. 80:159-169.
22. Lossos, I.S., R. Tibshirani, B. Narasimhan, and R. Levy. 2000. The inference of antigen selection on Ig genes. J. Immunol. 165:5122-5126.
23. Shin, M.S., T.N. Fredrickson, J.W. Hartley, T. Suzuki, K. Agaki, and H.C. Morse III. 2004. High throughput retroviral tagging for identification of genes involved in initiation and progression of mouse splenic marginal zone lymphomas. Cancer Res. 64:4419-4427.
24. Reap, E.A., M.L. Piecyk, A. Oliver, E.S. Sobel, T. Waldschmidt, P.L. Cohen, and R.A. Eisenberg. 1996. Phenotypic abnormalities of splenic and bone marrow B cells in lpr and gld mice. Clin. Immunol. Immunopathol. 78:21-29.
25. Mandik-Nayak, L., S.J. Seo, C. Sokol, K.M. Potts, A. Bui, and J. Erikson. 1999. MRL-lpr/lpr mice exhibit a defect in maintaining developmental arrest and follicular exclusion of anti-double-stranded DNA B cells. J. Exp. Med. 189:1799-1814.
26. Theofilopoulos, A., R.S. Balderas, L. Hang, and F.J. Dixon. 1983. Monoclonal IgM rheumatoid factors derived from MRL/Mp-lpr/lpr mice. J. Exp. Med. 158:901-919.
27. Haines, B.B., C.V. Angeles, A.P. Parmelee, P.A. McLean, and P.H. Brodeur. 2001. Germline diversity of the expressed BALB/c VhJ558 gene family. Mol. Immunol. 38:9-18.
28. Brodeur, P.H., and R. Riblet. 1984. The immunoglobulin heavy chain variable region (Igh-V) locus in the mouse. I. One hundred Igh-V genes comprise seven families of homologous genes. Eur. J. Immunol. 14:922-930.
29. Kantor, A.B., C.E. Merrill, L.A. Herzenberg, and J.L. Hillson. 1997. An unbiased analysis of V(H)-D-J(H) sequences from B-1a, B-1b, and conventional B cells. J. Immunol. 158: 1175-1186.
30. Krishnan, M.R., N.T. Jou, and T.N. Marion. 1996. Correlation between the amino acid position of arginine in VH-CDR3 and specificity for native DNA among autoimmune antibodies. J. Immunol. 157:2430-2439.
31. Kalled, S.L., and P.H. Brodeur. 1991. Utilization of Vκ families and Vκ exons. Implications for the available B cell repertoire. J. Immunol. 147:3194-3200.
32. Whitcomb, E.A., and P.H. Brodeur. 1998. Rearrangement and selection in the developing Vκ repertoire of the mouse: an analysis of the usage of two Vκ gene segments. J. Immunol. 160:4904-4913.
33. Morse, H.C., T. McCarty, C.-F. Qi, E.A. Torrey, Z. Naghashfar, S.K. Chattopadhyay, T.N. Fredrickson, and J.W. Hartley. 2004. B lymphoid neoplasms of mice: characteristics of naturally occuring and engineered diseases and relationships to human disorders. Adv. Immunol. 81:97-121.
34. Nakamuta, M., K. Oka, J. Krushka, K. Kobayashi, M. Yamamoto, W.H. Li, and L. Chan. 1995. Alternative mRNA splicing and differential promoter utilization determine tissue-specific expression of the apolipoprotein B mRNA-editing protein (Apobec1) gene in mice. Structure and evolution of Apobec1 and related nucleoside/nucleotide deaminases. J. Biol. Chem. 270:13042-13056.
35. Harris, R.S., S.K. Petersen-Mahrt, and M.S. Neuberger. 2002. RNA editing enzyme APOBEC1 and some of its homologs can act as DNA mutators. Mol. Cell. 10:1247-1253.
36. Tarte, K., F. Zhan, J. De Vos, B. Klein, and J. Shaughnessy. 2003. Gene expression profiling of plasma cells and plasma-blasts: toward a better understanding of the late stages of B-cell differentiation. Blood. 102:592-600.
37. Underbill, G.H., D. George, E.G. Bremer, and G.S. Kansas. 2003. Gene expression profiling reveals a highly specialized genetic program of plasma cells. Blood. 101:4013-4021.
38. Hromas, R., S.J. Collins, D. Hickstein, W. Raskind, L.L. Deaven, P. O'Hara, F.S. Hagen, and K. Kaushansky. 1991. A retinoic acid-responsive human zinc finger gene, MZF-1, preferentially expressed in myeloid cells. J. Biol. Chem. 266: 14183-14187.
39. Li, L., and S.N. Cohen. 1996. Tsg101: a novel tumor susceptibility gene isolated by controlled homozygous functional knockout of allelic loci in mammalian cells. Cell. 85:319-329.
40. Day, C.D., N.J. Smilinich, G.V. Fitzpatrick, P.J. deJong, T.B. Shows, and M.J. Higgins. 1999. The imprinted domain in mouse distal Chromosome 7: reagents for mutagenesis and sequencing. Mamm. Genome. 10:182-185.
41. Guehenneux, F., L. Duret, M.B. Callanan, R. Bouhas, R. Hayette, C. Berthet, C. Samarut, R. Rimokh, A.M. Birot, Q. Wang, et al. 1997. Cloning of the mouse BTG3 gene and definition of a new gene family (the BTG family) involved in the negative control of the cell cycle. Leukemia. 11:370-375.
42. Ge, K., J. Duhadaway, D. Sakamuro, R. Wechsler-Reya, C. Reynolds, and G.C. Prendergast. 2000. Losses of the tumor suppressor BIN1 in breast carcinoma are frequent and reflect deficits in programmed cell death capacity. Int. J. Cancer. 85: 376-383.
43. Su, T.T., B. Guo, Y. Kawakami, K. Sommer, K. Chae, L.A. Humphries, R.M. Kato, S. Kang, L. Patrone, R. Wall, et al. 2002. PKC-beta controls I kappa B kinase lipid raft recruitment and activation in response to BCR signaling. Nat. Immunol. 3:780-786.
44. Tsukasaki, K., C.W. Miller, E. Greenspun, S. Eshaghian, H. Kawabata, T. Fujimoto, M. Tomonaga, C. Sawyers, J.W. Said, and H.P. Koeffler. 2001. Mutations in the mitotic check point gene, MAD1L1, in human cancers. Oncogens. 20:3301-3305.
45. Moreaux, J., E. Legouffe, E. Jourdan, P. Quittet, T. Reme, C. Lugagne, P. Moine, J. Rossi, B. Klein, and K. Tarte. 2004. BAFF and APRIL protect myeloma cells from apoptosis induced by interleukin 6 deprivation and dexamethasone. Blood. 103:3148-3157.
46. He, B., A. Chadburn, E. Jou, E.J. Schattner, D.M. Knowles, and A. Cerutti. 2004. Lymphoma B cells evade apoptosis through the TNF family members BAFF/BLyS and APRIL. J. Immunol. 172:3268-3279.
47. Novak, A.J., J.R. Darce, B.K. Arendt, B. Harder, K. Henderson, W. Kindsvogel, J.A. Gross, P.R. Greipp, and D.F. Jelinek. 2004. Expression of BCMA, TACI, and BAFF-R in multiple myeloma: a mechanism for growth and survival. Blood. 103:689-694.
48. Masood, R., Y. Zhang, M.W. Bond, D.T. Scadden, T. Moudgil, R.E. Law, M.H. Kaplan, B. Jung, B.M. Espina, and Y. Lunardi-Iskandar. 1995. Interleukin-10 is an autocrine growth factor for acquired immunodeficiency syndrome-related B-cell lymphoma. Blood. 85:3423-3430.
49. Lu, Z.Y., X.G. Zhang, C. Rodriguez, J. Wijdenes, Z.J. Gu, B. Morel-Fournier, J.L. Harousseau, R. Bataille, J.F. Rossi, and B. Klein. 1995. Interleukin-10 is a proliferation factor but not a differentiation factor for human myeloma cells. Blood. 85:2521-2527.
50. Groux, H., and F. Cottrez. 2003. The complex role of interleukin-10 in autoimmunity. J. Autoimmun. 20:281-285.
51. Lopatin, U., X. Yao, R.K. Williams, J.K. Bleesing, J.K. Dale, D. Wong, J. Teruya-Feldstein, S. Fritz, M.R. Morrow, I. Fuss, et al. 2001. Increases in circulating and lymphoid tissue interleukin-10 in autoimmune lymphoproliferative syndrome are associated with disease expression. Blood. 97:3161-3170.
52. Rozzo, S.J., J.D. Allard, D. Choubey, T.J. Vyse, S. Izui, G. Peltz, and B.L. Kotzin. 2001. Evidence for an interferon-inducible gene, Ifi202, in the susceptibility to systemic lupus. Immunity. 15:435-443.
53. Saito, M., K. Yoshida, M. Hibi, T. Taga, and T. Kishimoto. 1992. Molecular cloning of a murine IL-6 receptor-associated signal transducer, gp130, and its regulated expression in vivo. J. Immunol. 148:4066-4071.
54. Kompfner, E., P. Oliveira, A. Montalbano, and A.J. Feeney. 2001. Unusual germline DSP2 gene accounts for all apparent V-D-D-J rearrangements in newborn, but not adult, MRL mice. J. Immunol. 167:6933-6938.
55. Klonowski, K.D., and M. Monestier. 2000. Heavy chain revision in MRL mice: a potential mechanism for the development of autoreactive B cell precursors. J. Immunol. 165:4487-4493.
56. Radic, M.Z., J. Erikson, S. Litwin, and M. Weigert. 1993. B lymphocytes may escape tolerance by revising their antigen receptors. J. Exp. Med. 177:1165-1173.
57. Brard, F., M. Shannon, E.L. Prak, S. Litwin, and M. Weigert. 1999. Somatic mutation and light chain rearrangement generate autoimmunity in anti-single-stranded DNA transgenic MRL/lpr mice. J. Exp. Med. 190:691-704.
58. Li, H., Y. Jiang, E.L. Prak, M. Radic, and M. Weigert. 2001. Editors and editing of anti-DNA receptors. Immunity. 15: 947-957.
59. Monestier, M., and M. Zouali. 2002. Receptor revision and systemic lupus. Scand. J. Immunol. 55:425-431.
60. Chen, C., Z. Nagy, E.L. Prak, and M. Weigert. 1995. Immunoglobulin heavy chain gene replacement: a mechanism of receptor editing. Immunity. 3:747-755.
61. Wilson, P.C., K. Wilson, Y.J. Liu, J. Banchereau, V. Pascual, and J.D. Capra. 2000. Receptor revision of immunoglobulin heavy chain variable region genes in normal human B lymphocytes. J. Exp. Med. 191:1881-1894.
62. Fanning, L., F.E. Bertrand, C. Steinberg, and G.E. Wu. 1998. Molecular mechanisms involved in receptor editing at the Ig heavy chain locus. Int. Immunol. 10:241-246.
63. Smit, L.A., R.J. Bende, J. Aten, J.E. Guikema, W.M. Aarts, and C.J. van Noesel. 2003. Expression of activation-induced cytidine deaminase is confined to B-cell non-Hodgkin's lymphomas of germinal-center phenotype. Cancer Res. 63:3894-3898.
64. Greeve, J., A. Philipsen, K. Krause, W. Klapper, K. Heidorn, B.E. Castle, J. Janda, K.B. Marcu, and R. Parwaresch. 2003. Expression of activation-induced cytidine deaminase in human B-cell non-Hodgkin lymphomas. Blood. 101:3574-3580.
65. Weng, W.K., and S. Levy. 2003. Hepatitis C virus (HCV) and lymphomagenesis. Leuk. Lymphoma. 44:1113-1120.
66. Isaacson, P.G. 1999. Mucosa-associated lymphoid tissue lymphoma. Semin. Hematol. 36:139-147.
67. Crump, M., M. Gospodarowicz, and F.A. Shepherd. 1999. Lymphoma of the gastrointestinal tract. Semin. Oncol. 26: 324-337.
68. Dammacco, F., D. Sansonno, C. Piccoli, V. Racanelli, P.P. D'Amore, and G. Lauletta. 2000. The lymphoid system in hepatitis C virus infection: autoimmunity, mixed cryoglobulinemia, and overt B-cell malignancy. Semin. Liver Dis. 20: 143-157.
69. Shlomchik, M.J., C.W. Euler, S.C. Christensen, and J. William. 2003. Activation of rheumatoid factor (RF) B cells and somatic hypermutation outside of germinal centers in autoimmune-prone MRL/lpr mice. Ann. NY Acad. Sci. 987: 38-50.
70. Doyle, H.A., J. Van, B. Liang, and M.J. Mamula. 2001. Lupus autoantigens: their origins, forms, and presentation. Immunol. Res. 24:131-147.
71. Okazaki, I.M., H. Hiai, N. Kakazu, S. Yamada, M. Muramatsu, K. Kinoshita, and T. Honjo. 2003. Constitutive expression of AID leads to tumorigenesis. J. Exp. Med. 197: 1173-1181.
72. Yamanaka, S., M.E. Balestra, L.D. Ferrell, J. Fan, K.S. Arnold, S. Taylor, J.M. Taylor, and T.L. Innerarity. 1995. Apolipoprotein B mRNA-editing protein induces hepatocellular carcinoma and dysplasia in transgenic animals. Proc. Natl. Acad. Sci. USA. 92:8483-8487.
73. Su, T.T., B. Guo, Y. Kawakami, K. Sommer, K. Chae, L.A. Humphries, R.M. Kato, S. Kang, L. Patrone, R. Wall, et al. 2002. PKC-β controls IκB kinase lipid raft recruitment and activation in response to BCR signaling. Nat. Immunol. 3:780-786.
74. Pramanik, R., T.N. Jorgensen, H. Xin, B.L. Kotzin, and D. Choubey. 2004. Interleukin-6 induces expression of Ifi202, an interferon-inducible candidate gene for lupus susceptibility. J. Biol. Chem. 279:16121-16127.
75. Elliott, K., D. Sakamuro, A. Basu, W. Du, W. Wunner, P. Staller, S. Gaubatz, H. Zhang, E. Prochownik, M. Eilers, and G.G. Prendergast. 1999. Bin1 functionally interacts with Myc and inhibits cell proliferation via multiple mechanisms. Oncogene. 18:3564-3573.